JMJD3/HDAC-IN-1

Modify Date: 2024-01-23 15:58:53

JMJD3/HDAC-IN-1 Structure
JMJD3/HDAC-IN-1 structure
Common Name JMJD3/HDAC-IN-1
CAS Number 2883046-06-6 Molecular Weight 398.50
Density N/A Boiling Point N/A
Molecular Formula C21H30N6O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of JMJD3/HDAC-IN-1


JMJD3/HDAC-IN-1 (compound A5b) is a dual inhibitor targeting Jumonji domain-containing protein demethylase 3 (JMJD3) and histone deacetylase (HADC1, IC50=16 nM). JMJD3/HDAC-IN-1 promotes hypermethylation of histone H3K27 and hyperacetylation of H3K9, and also cleaves caspase-7 and PARP to induce apoptosis. JMJD3/HDAC-IN-1 effectively inhibits cancer cell cloning, migration, and invasion[1].

 Names

Name JMJD3/HDAC-IN-1

 JMJD3/HDAC-IN-1 Biological Activity

Description JMJD3/HDAC-IN-1 (compound A5b) is a dual inhibitor targeting Jumonji domain-containing protein demethylase 3 (JMJD3) and histone deacetylase (HADC1, IC50=16 nM). JMJD3/HDAC-IN-1 promotes hypermethylation of histone H3K27 and hyperacetylation of H3K9, and also cleaves caspase-7 and PARP to induce apoptosis. JMJD3/HDAC-IN-1 effectively inhibits cancer cell cloning, migration, and invasion[1].
Related Catalog
Target

IC50: 16 nM (HDAC1), 534 nM (HDAC6)[1]

References

[1]. Li A, et al. Design, synthesis and biological evaluation of pyrimidine base hydroxamic acid derivatives as dual JMJD3 and HDAC inhibitors. Bioorg Med Chem Lett. 2023 Oct 1;94:129466.. .  

 Chemical & Physical Properties

Molecular Formula C21H30N6O2
Molecular Weight 398.50